Quarterly ResultAug 13, 2026, 07:09 AM
Rockwell Medical Q2 Net Sales Up 10.6% to $17.78M; Net Loss Improves
AI Summary
Rockwell Medical, Inc. reported a 10.6% increase in net sales for the second quarter of 2026, reaching $17.78 million, while its net loss improved to $(1.17) million from $(1.49) million in the prior year. For the six months ended June 30, 2026, the company generated $1.91 million in net cash from operating activities, a significant improvement from a net cash usage of $(1.64) million in the same period last year. The company also completed a 1-for-10 reverse stock split on July 1, 2026, and maintains $24.8 million in cash, cash equivalents, and investments.
Key Highlights
- Q2 2026 net sales increased 10.6% to $17.78 million.
- Q2 2026 net loss improved to $(1.17) million from $(1.49) million.
- YTD 2026 net cash provided by operating activities was $1.91 million.
- Total cash, cash equivalents, and investments were $24.8 million as of June 30, 2026.
- Working capital stood at $25.2 million as of June 30, 2026.
- A 1-for-10 reverse stock split was effected on July 1, 2026.
- The company is in compliance with all loan covenants.
Price Impact
More from RMTI